Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury

Fig. 5

The HPLC chromatograms for determination of TMP (300 µg/mL) and coumarin (internal standard, 10 µg/mL). Plasma: Blank plasma (a); plasma spiked with TMP and coumarin (b). Heart: blank heart tissue homogenate (c); TMP and coumarin spiked in heart tissue homogenate (d). Liver: blank liver tissue homogenate (e); TMP and coumarin spiked in liver tissue homogenate (f). Spleen: blank spleen tissue homogenate (g); TMP and coumarin spiked in spleen tissue homogenate (h). Lung: blank lung tissue homogenate (i); lung tissue homogenate spiked with TMP and coumarin (j). Kidney: blank kidney tissue homogenate (k); TMP and coumarin spiked in kidney tissue homogenate (l). Spinal cord: blank tissue homogenate (m); TMP and coumarin spiked in spinal cord tissue homogenate (n). a is tetramethylpyrazine, and b is internal standard (coumarin)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us